Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis

Patricia Santofimia‐Castaño(Centre National de la Recherche Scientifique), Juan Iovanna(Centre National de la Recherche Scientifique)
Journal of Clinical Investigation
March 28, 2019
Cited by 104


Related Papers